...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Preoperative steroid use and the incidence of perioperative complications in patients undergoing craniotomy for definitive resection of a malignant brain tumor
【24h】

Preoperative steroid use and the incidence of perioperative complications in patients undergoing craniotomy for definitive resection of a malignant brain tumor

机译:开颅手术彻底切除恶性脑肿瘤患者术前使用类固醇激素和围手术期并发症的发生率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We studied the impact of preoperative steroids on 30 day morbidity and mortality of craniotomy for definitive resection of malignant brain tumors. Glucocorticoids are used to treat peritumoral edema in patients with malignant brain tumors, however, prolonged (>= 10 days) use of preoperative steroids as a risk factor for perioperative complications following resection of brain tumors has not been studied comprehensively. Therefore, we identified 4407 patients who underwent craniotomy to resect a malignant brain tumor between 2007 and 2012, who were reported in the National Surgical Quality Improvement Program, a prospectively collected clinical database. Metastatic brain tumors constituted 37.5% (n = 1611) and primary malignant gliomas 62.5% (n = 2796) of the study population. We used logistic regression to assess the association between preoperative steroid use and perioperative complications before and after 1:1 propensity score matching. Patients who received steroids constituted 22.8% of the population (n = 1009). In the unmatched cohort, steroid use was associated with decreased length of hospitalization (odds ratio [OR] 0.7; 95% confidence interval [CI] 0.6-0.8), however, the risk for readmission (OR 1.5; 95% CI 1.2-1.8) was increased. In the propensity score matched cohort (n = 465), steroid use was not statistically associated with any adverse outcomes. Patients who received steroids were less likely to stay hospitalized for a protracted period of time, but were more likely to be readmitted after discharge following craniotomy. As an independent risk factor, preoperative steroid use was not associated with any observed perioperative complications. The findings of this study suggest that preoperative steroids do not independently compromise the short term outcome of craniotomy for resection of malignant brain tumors. (C) 2015 Elsevier Ltd. All rights reserved.
机译:我们研究了术前类固醇对确定性切除恶性脑肿瘤开颅手术30天发病率和死亡率的影响。糖皮质激素被用于治疗恶性脑肿瘤患者的肿瘤周围水肿,但是,术前使用类固醇激素作为切除脑肿瘤术后围手术期并发症的危险因素的时间延长(> = 10天)尚未得到全面研究。因此,我们确定了2007年至2012年之间开颅手术切除恶性脑肿瘤的4407例患者,这些患者在前瞻性收集的临床数据库国家手术质量改善计划中报告。转移性脑肿瘤占研究人群的37.5%(n = 1611),原发性恶性神经胶质瘤占62.5%(n = 2796)。我们使用逻辑回归评估了1:1倾向评分匹配前后术前使用类固醇激素与围手术期并发症之间的关系。接受类固醇治疗的患者占总人口的22.8%(n = 1009)。在无与伦比的队列研究中,类固醇的使用与住院时间缩短有关(赔率[OR] 0.7; 95%置信区间[CI] 0.6-0.8),但是,再次入院的风险(OR 1.5; 95%CI 1.2-1.8) )增加了。在倾向评分匹配的队列中(n = 465),类固醇的使用与任何不良预后均无统计学关系。接受类固醇激素治疗的患者在长期住院的可能性较小,但在开颅手术后出院后更有可能再次入院。作为一个独立的危险因素,术前使用类固醇激素与围手术期并发症无关。这项研究的结果表明,术前使用类固醇不会单独损害开颅手术切除恶性脑肿瘤的短期结果。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号